Indications of Ostan 25 mg
Hypertension: It is recommended to use Ostan 25 mg to treat hypertension. It could be used with other antihypertensive medications or taken alone (eg. thiazide diuretics). Renal Protection in Type-2 Diabetic Patients with Proteinuria: In hypertensive type-2 diabetics with proteinuria, which is defined as urine albumin to creatinine ratio >300 mg/g, Ostan 25 mg is advised to postpone the advancement of renal disease.
Theropeutic Class
Angiotensin-ll receptor blocker
Pharmacology
The first angiotensin II receptor blocker that is orally active without a peptide is Ostan 25 mg. It binds to the AT1 receptor, which is present in numerous tissues (such as the heart, kidneys, adrenal glands, and vascular smooth muscle), and inhibits several critical biological processes, such as vasoconstriction and the production of the hormone aldosterone that causes hypertension.
Dosage & Administration of Ostan 25 mg
For the majority of patients, the beginning and maintenance dose is 50 mg once daily. Prior to raising the dose, 25 mg twice daily is advised if the antihypertensive impact of 50 mg once daily is insufficient. A starting dose of 25 mg once daily should be taken into consideration for individuals with intravascular volume depletion (such as those on high-dose diuretics). One or two doses of Ostan 25 mg can be given each day. From 25 mg to 100 mg is the range for the total daily dose.
Dosage of Ostan 25 mg
For the majority of patients, the beginning and maintenance dose is 50 mg once daily. Prior to raising the dose, 25 mg twice daily is advised if the antihypertensive impact of 50 mg once daily is insufficient. A starting dose of 25 mg once daily should be taken into consideration for individuals with intravascular volume depletion (such as those on high-dose diuretics). One or two doses of Ostan 25 mg can be given each day. From 25 mg to 100 mg is the range for the total daily dose.
Interaction of Ostan 25 mg
Levels of the Ostan 25 mg active metabolite are decreased by rifampicin and fluconazole. The antihypertensive effects of hydrochlorothiazide and Ostan 25 mg used together may be potentiated. Increases in serum potassium may result from the concurrent use of potassium-sparing diuretics (such as spironolactone, triamterene, and amiloride), potassium supplements, or salt substitutes containing potassium. The non-steroidal anti-inflammatory medicine indomethacin may lessen the antihypertensive effects of losartan. The risk of renal impairment is increased by the concurrent use of an ACE inhibitor, an angiotensin receptor antagonist, an anti-inflammatory medication, and a thiazide diuretic.
Contraindications
Pregnant women and individuals who are hypersensitive to any ingredient in this medication should not use Ostan 25 mg. Those with diabetes shouldn't take Aliskiren and Ostan 25 mg together.
Side Effects of Ostan 25 mg
Ostan 25 mg side effects are minor and short-lived in nature. Dizziness, diarrhea, nasal congestion, coughing, and upper respiratory infections are the most frequent adverse effects. Fatigue, oedema, chest pain, nausea, headaches, and pharyngitis are other adverse effects.
Pregnancy & Lactation
Category D for pregnancies. If Ostan 25 mg is given during the second or third trimester of pregnancy, the risk to the fetus increases. Given that numerous medicines are excreted in human milk and that it is unknown whether Ostan 25 mg is one of them, a choice should be taken regarding whether to stop breastfeeding or stop taking the medication, taking into account the significance of the medication to the mother.
Precautions & Warnings
In addition to increasing fetal and neonatal morbidity and mortality, the use of Ostan 25 mg throughout the second and third trimesters of pregnancy decreases fetal renal function. Symptomatic hypotension may happen in people who are intravascularly volume-depleted (such as those taking high-dose diuretics). Patients with cirrhosis have a considerably higher plasma concentration of Ostan 25 mg. Patients with renal impairment have experienced changes in renal function, including renal failure.
Storage Conditions
Keep dry and away from heat and light. Keep out of children's reach.
Drug Classes
Angiotensin-ll receptor blocker
Mode Of Action
The first angiotensin II receptor blocker that is orally active without a peptide is Ostan 25 mg. It binds to the AT1 receptor, which is present in numerous tissues (such as the heart, kidneys, adrenal glands, and vascular smooth muscle), and inhibits several critical biological processes, such as vasoconstriction and the production of the hormone aldosterone that causes hypertension.
Pregnancy
Category D for pregnancies. If Ostan 25 mg is given during the second or third trimester of pregnancy, the risk to the fetus increases. Given that numerous medicines are excreted in human milk and that it is unknown whether Ostan 25 mg is one of them, a choice should be taken regarding whether to stop breastfeeding or stop taking the medication, taking into account the significance of the medication to the mother.